← Back to Clinical Trials
Recruiting NCT05937334

The Cohort Study for Asthma in China

Trial Parameters

Condition Asthma, Bronchial
Sponsor Beijing Chao Yang Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 400
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-01-01
Completion 2027-12-31
Interventions
Diagnostic Test: lung function test, chest CT, induced sputum, blood routine test, IgE test, FeNO test, six minutes walk test, questionnaires for asthma

Brief Summary

The study is to establish a standardized asthma cohort study, build an information network platform system and a biospecimen bank for asthma cohort, establish clear follow-up standards and norms, observe the asthma outcomes and identify biomarkers to predict asthma outcomes.

Eligibility Criteria

Inclusion Criteria: * Age \>18 * Meet the 2023 edition of GINA asthma diagnostic criteria * Subjects must sign informed consent prior to study participation, participate in the study according to the protocol and follow up for 2 years Exclusion Criteria: * Suffering from other massive lung tissue destructive diseases such as severe bronchiectasis and tuberculosis * Severe pleural disease and/or sternal and rib lesions * Serious uncontrolled disease of other system * Thoracic or abdominal surgery in the past 3 months * Eye surgery in the past three months * Retina detachment * Myocardial infarction within the last 3 months * Hospitalized for heart disease within the past 3 months * Ongoing anti-tuberculosis treatment * Pregnancy or breast feeding

Related Trials